相关实验视频
Updated: Jan 15, 2026

05:42
The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
39.6K
概括
埃斯基塔洛普拉姆酸盐 (ESC) 通过向血清素转运基因 (SLC6A4) 和调节HPA轴,有效治疗失眠. 这项研究证实了ESC的观点.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 遗传学 遗传学是一种遗传学.
背景情况:
- 埃斯基塔洛普拉姆酸盐 (ESC) 已被认为可以改善抑郁症和焦虑症患者的失眠.
- 血清素载体基因 (SLC6A4) 在失眠调节中发挥作用.
- 通过ESC影响SLC6A4表达来缓解失眠的精确机制仍在调查中.
研究的目的:
- 研究ESC是否通过调节SLC6A4表达来改善失眠.
- 阐明ESC对睡眠,焦虑和抑郁的影响背后的分子机制.
- 通过临床和动物实验模型验证发现.
主要方法:
- 临床研究涉及110名参与者,使用便携式睡眠脑电图监视器和HAMA14/HAMD24尺度进行评估.
- 使用18只ICR雄性小鼠进行动物研究,评估睡眠,焦虑和抑郁行为,并进行组织学和分子分析 (H&E,ELISA,IHC,Western blot).
- 使用PubChem,DrugBank和治疗目标数据库进行生物信息分析,以预测ESC的分子目标.
主要成果:
- 在人类参与者和小鼠中,ESC显著改善了睡眠质量,减少了睡眠延迟,并减轻了焦虑和抑郁.
- 在小鼠中,ESC减轻了海马组织损伤,使神经递质水平 (5-HT,GABA,NE,Glu) 正常化,并调节了HPA轴激素 (CRH,ACTH,CORT).
- SLC6A4被确定为ESC的潜在标,ESC显著抑制SLC6A4的表达,并调节海马组织中的5-HTR1A和5-HTR2A的表达.
结论:
- 在治疗失眠方面,ESC在临床上是有效的.
- 通过准SLC6A4,ESC可以改善失眠,从而调节下丘脑-垂体-上腺 (HPA) 轴.
- 这些发现提供了对ESC对失眠的治疗效果的机制性理解.
相关概念视频
Sedatives and Hypnotics Drugs: Miscellaneous Agents
508
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
508
Management of Insomnia
528
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
528
Sedatives and Hypnotics: Overview
1.4K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
1.4K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.4K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.4K
Antidepressant Drugs: MAOIs and Other Agents
806
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
806
Insomnia
400
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
400

